Successful treatment of psoriasis with low-dose per os interleukins 4, 10, and 11
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F15%3A10294954" target="_blank" >RIV/00216208:11130/15:10294954 - isvavai.cz</a>
Alternative codes found
RIV/00064211:_____/15:#0000469
Result on the web
<a href="http://dx.doi.org/10.1111/dth.12174" target="_blank" >http://dx.doi.org/10.1111/dth.12174</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/dth.12174" target="_blank" >10.1111/dth.12174</a>
Alternative languages
Result language
angličtina
Original language name
Successful treatment of psoriasis with low-dose per os interleukins 4, 10, and 11
Original language description
Roberti et al. [1] have recently reported on the successful immunomodulating treatment with simultaneously administered low-dose interleukins (ILs)-4, -10, and -11 in the treatment of psoriasis vulgaris. This treatment is an example of therapies based onthe Physiological Regulation Medicine concepts. Physiological Regulation Medicine represents the most up-to-date integration of low-dose medicine with the innovative therapeutic concept of restoring physiology through activated low dose of communicatingmolecules such as hormones, neuropeptides, interleukins, and growth factors. The low-dose preparation method, called sequential kinetic activation (SKA), seems to make communicating molecules more effective, providing a biofeedback mechanism capable ofrestoring the psyco-neuro-immuno-endocrine homeostatic balance [2-5]. This concept represents the "functional core" of low-dose medicine. Thanks to SKA technology (the "technical core" of low-dose medicine), it is now possible to use lowe
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FO - Dermatology and venereology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Dermatologic Therapy
ISSN
1396-0296
e-ISSN
—
Volume of the periodical
28
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
2
Pages from-to
1-2
UT code for WoS article
000347896100001
EID of the result in the Scopus database
2-s2.0-84920920793